StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN)

StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Thursday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of NASDAQ LPCN opened at $2.94 on Thursday. Lipocine has a 1 year low of $2.31 and a 1 year high of […]

Leave a Reply

Your email address will not be published.

Previous post McDonald’s (NYSE:MCD) Earns Buy Rating from Analysts at HSBC
Next post Signature Bank (NASDAQ:SBNY) Now Covered by Analysts at StockNews.com